Cargando…
Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011–2014): a cross-sectional study
BACKGROUND: Although gabapentin has been licensed in the European Union only for neuropathic pain and epilepsy for patients who have partial seizures, it has also been prescribed in treatment for substance use disorders. Many studies report the potential risk of abuse of gabapentin by people with su...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858131/ https://www.ncbi.nlm.nih.gov/pubmed/29560269 http://dx.doi.org/10.1186/s13690-018-0254-8 |